Capella Scientia Development Study
Capella Scientia (SCDX) Development Study
Alcon Research
400 participants
Jul 30, 2025
OBSERVATIONAL
Conditions
Summary
This study involves collecting biometry and aberration data using the next generation biometer, Unity DX.
Eligibility
Inclusion Criteria3
- Able to understand and sign an IRB/IEC approved consent form;
- Willing and able to attend study visit(s) as required by the protocol;
- Consenting age at the jurisdiction of study site;
Exclusion Criteria5
- Women of child-bearing potential;
- Unable to fixate due to nystagmus or other eye movement abnormality (e.g., significant strabismus);
- Unclear optical media preventing data capture from all devices in the study;
- Contraindicated for pupil dilation (e.g., narrow angles, allergies) per investigator's clinical judgment;
- Any ocular disease and/or condition that, in the investigator's clinical judgment, may put the subject at significant risk, may compromise study results, or may interfere significantly with the subject's participation in the study;
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Unity DX is a CE-marked, noninvasive, noncontact instrument that generates a 3D model of the eye using hyper parallel optical coherence tomography (HP OCT), aberrometry, and topography. The current version of SCDX software will be used in this study.
The IOLMaster 700 Biometer is a CE-marked, noninvasive, noncontact instrument that captures optical biometry. Data will be collected using standard clinical assessments.
The Argos with Alcon Image Guidance biometer is a CE-marked, noninvasive, noncontact instrument that will capture optical biometry. Data will be collected using standard clinical assessments.
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06987474